Targeting APLN/APJ restores blood-testis barrier and improves spermatogenesis in murine and human diabetic models
Type 2 diabetes often presents with reproductive disorders, including reduced male and female fertility. Here they show that diabetes disrupts the APLN signaling axis in the testes and that spermatogenesis can be restored through treatment with an APLN antagonist.
Main Authors: | Ke Song, Xinyan Yang, Geng An, Xinyu Xia, Jiexiang Zhao, Xiaoheng Xu, Cong Wan, Tianyuan Liu, Yi Zheng, Shaofang Ren, Mei Wang, Gang Chang, Shane J. F. Cronin, Josef M. Penninger, Tao Jing, Xianghong Ou, Shuan Rao, Zhaoting Liu, Xiao-Yang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-34990-3 |
Similar Items
-
Emerging roles of APLN and APELA in the physiology and pathology of the female reproductive system
by: Xueying Wang, et al.
Published: (2020-11-01) -
Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
by: Walden, C, et al.
Published: (2007) -
APLN/APLNR Signaling Controls Key Pathological Parameters of Glioblastoma
by: Roland E. Kälin, et al.
Published: (2021-08-01) -
Transcriptomic Study of Spermatogenesis in the Testis of Hu Sheep and Tibetan Sheep
by: Xiaoyu Fu, et al.
Published: (2022-11-01) -
The Decellularized Calf Testis: Introducing Suitable Scaffolds for Spermatogenesis Studies
by: Mohammad Rasool Khazaei, et al.
Published: (2024-01-01)